(29) reported a case of advanced NSCLC patient with 100% PD-L1 expression who experienced HPD after two cycles of pembrolizumab treatment, which was controlled by chemotherapy and allowed for long-term stability. Here, CD274 is linked to non-small cell lung carcinoma.